141 related articles for article (PubMed ID: 34341476)
1. PAX3/7-FOXO1 fusion-negative alveolar rhabdomyosarcoma in Schuurs-Hoeijmakers syndrome.
Ohkawa T; Nishimura A; Kosaki K; Aoki-Nogami Y; Tomizawa D; Kashimada K; Morio T; Kato M; Mizutani S; Takagi M
J Hum Genet; 2022 Jan; 67(1):51-54. PubMed ID: 34341476
[TBL] [Abstract][Full Text] [Related]
2. Schuurs-Hoeijmakers syndrome in two patients from Japan.
Hoshino Y; Enokizono T; Imagawa K; Tanaka R; Suzuki H; Fukushima H; Arai J; Sumazaki R; Uehara T; Takenouchi T; Kosaki K
Am J Med Genet A; 2019 Mar; 179(3):341-343. PubMed ID: 30588754
[TBL] [Abstract][Full Text] [Related]
3. Prenatal and postnatal diagnosis of Schuurs-Hoeijmakers syndrome: Case series and review of the literature.
Seto MT; Bertoli-Avella AM; Cheung KW; Chan KY; Yeung KS; Fung JL; Beetz C; Bauer P; Luk HM; Lo IF; Lee CP; Chung BH; Kan AS
Am J Med Genet A; 2021 Feb; 185(2):384-389. PubMed ID: 33166031
[TBL] [Abstract][Full Text] [Related]
4. Genetic characterization of Schuurs-Hoeijmakers syndrome in a moroccan individual with heterozygote PACS1 mutation.
Abbassi M; Bourmtane A; Sayel H; El Mouhi H; Jalte M; Elasri YA; Askander O; El Fahime E; Bouguenouch L
Mol Biol Rep; 2023 Nov; 50(11):9121-9128. PubMed ID: 37747683
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects.
Loupe JM; Miller PJ; Bonner BP; Maggi EC; Vijayaraghavan J; Zabaleta J; Taylor CM; Tsien F; Crabtree JS; Hollenbach AD
Oncotarget; 2016 Sep; 7(39):62814-62835. PubMed ID: 27588498
[TBL] [Abstract][Full Text] [Related]
6. Regulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elements.
Vicente-García C; Villarejo-Balcells B; Irastorza-Azcárate I; Naranjo S; Acemel RD; Tena JJ; Rigby PWJ; Devos DP; Gómez-Skarmeta JL; Carvajal JJ
Genome Biol; 2017 Jun; 18(1):106. PubMed ID: 28615069
[TBL] [Abstract][Full Text] [Related]
7. PAX3-FOXO1: Zooming in on an "undruggable" target.
Wachtel M; Schäfer BW
Semin Cancer Biol; 2018 Jun; 50():115-123. PubMed ID: 29146205
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of PAX3/7-FOXO1 fusion status in alveolar rhabdomyosarcoma: Systematic review and meta-analysis.
Kubo T; Shimose S; Fujimori J; Furuta T; Ochi M
Crit Rev Oncol Hematol; 2015 Oct; 96(1):46-53. PubMed ID: 26008753
[TBL] [Abstract][Full Text] [Related]
9. Loss of MST/Hippo Signaling in a Genetically Engineered Mouse Model of Fusion-Positive Rhabdomyosarcoma Accelerates Tumorigenesis.
Oristian KM; Crose LES; Kuprasertkul N; Bentley RC; Lin YT; Williams N; Kirsch DG; Linardic CM
Cancer Res; 2018 Oct; 78(19):5513-5520. PubMed ID: 30093562
[TBL] [Abstract][Full Text] [Related]
10. Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
Ahn EH
Anticancer Res; 2013 May; 33(5):2029-35. PubMed ID: 23645752
[TBL] [Abstract][Full Text] [Related]
11. A Novel PACS1 Variant Associated With Schuurs-Hoeijmakers Syndrome Phenotype in an Indigenous Descendant in Brazil: A Case Report.
Lucena PH; Nonaka C; Armani-Franceschi G; Carneiro P; Sales H; Lucena M; Bandeira ID; Solano B; Lucena R
Cureus; 2022 Oct; 14(10):e30486. PubMed ID: 36415352
[TBL] [Abstract][Full Text] [Related]
12. PAX3-NCOA1 alveolar rhabdomyosarcoma of the tongue: A rare entity with challenging diagnosis and management.
Di Carlo D; Chargari C; Scoazec JY; Cotteret S; Felix A; Moalla S; Temam S; Minard-Colin V
Pediatr Blood Cancer; 2021 Nov; 68(11):e29288. PubMed ID: 34424607
[TBL] [Abstract][Full Text] [Related]
13. Schuurs-Hoeijmakers Syndrome (
Tenorio-Castaño J; Morte B; Nevado J; Martinez-Glez V; Santos-Simarro F; García-Miñaúr S; Palomares-Bralo M; Pacio-Míguez M; Gómez B; Arias P; Alcochea A; Carrión J; Arias P; Almoguera B; López-Grondona F; Lorda-Sanchez I; Galán-Gómez E; Valenzuela I; Méndez Perez MP; Cuscó I; Barros F; Pié J; Ramos S; Ramos FJ; Kuechler A; Tizzano E; Ayuso C; Kaiser FJ; Pérez-Jurado LA; Carracedo Á; The ENoD-Ciberer Consortium ; The Side Consortium ; Lapunzina P
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34068396
[TBL] [Abstract][Full Text] [Related]
14.
Kendall GC; Watson S; Xu L; LaVigne CA; Murchison W; Rakheja D; Skapek SX; Tirode F; Delattre O; Amatruda JF
Elife; 2018 Jun; 7():. PubMed ID: 29869612
[TBL] [Abstract][Full Text] [Related]
15. Schuurs-Hoeijmakers syndrome in a patient from India.
Dutta AK
Am J Med Genet A; 2019 Apr; 179(4):522-524. PubMed ID: 30690871
[TBL] [Abstract][Full Text] [Related]
16. Fusion transcriptome profiling provides insights into alveolar rhabdomyosarcoma.
Xie Z; Babiceanu M; Kumar S; Jia Y; Qin F; Barr FG; Li H
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13126-13131. PubMed ID: 27799565
[TBL] [Abstract][Full Text] [Related]
17. Triple diagnosis of Wiedemann-Steiner, Waardenburg and DLG3-related intellectual disability association found by WES: A case report.
Matis T; Michaud V; Van-Gils J; Raclet V; Plaisant C; Fergelot P; Lasseaux E; Arveiler B; Trimouille A
J Gene Med; 2020 Aug; 22(8):e3197. PubMed ID: 32246869
[TBL] [Abstract][Full Text] [Related]
18. PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma.
Pandey PR; Chatterjee B; Olanich ME; Khan J; Miettinen MM; Hewitt SM; Barr FG
J Pathol; 2017 Apr; 241(5):626-637. PubMed ID: 28138962
[TBL] [Abstract][Full Text] [Related]
19. OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas.
Kaleta M; Wakulińska A; Karkucińska-Więckowska A; Dembowska-Bagińska B; Grajkowska W; Pronicki M; Łastowska M
Diagn Pathol; 2019 Sep; 14(1):103. PubMed ID: 31493794
[TBL] [Abstract][Full Text] [Related]
20.
Aljerian K
Fetal Pediatr Pathol; 2023 Jun; 42(3):385-393. PubMed ID: 36484735
[No Abstract] [Full Text] [Related]
[Next] [New Search]
